Nepal

in page functions
[French]
Nepal
Total population (2018) 29,521,717
Birth cohort (2018) 579,449
Surviving Infants (surviving to 1 year per year, 2018) 564,789
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 29/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 36/1000
World Bank Index, IDA (2015) 3.39
Gross Nation Income (per capita US$, 2015) 730
No. of districts/territories (2017) 77

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Nepal

Type of support

Approvals

2001-2023 (US$)
(23 May 2019)

Commitments

2001-2023 (US$)
(23 May 2019)

Disbursements

2000-2019 (US$)
(23 May 2019)

% Disbursed

(23 May 2019)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Total $154,438,118 $183,504,290 $150,685,433
Cash support (CASHSUPP) $199,000 $224,000 $199,000 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $628,633 $2,672,305 $628,633 100%
Health system strengthening (HSS 1) $8,667,000 $8,667,000 $8,667,000 100%
Health system strengthening (HSS 2) $14,483,745 $14,483,745 $14,483,745 100%
Health system strengthening (HSS 3) $22,620,000 $36,540,000 $19,140,000 85%
HepB mono (NVS) $1,870,980 $1,870,980 $1,870,980 100%
HPV Demo (NVS) $303,500 $303,500 $317,257 105%
Immunisation services support (ISS) $3,312,520 $3,312,520 $3,312,520 100%
Injection Safety Devices (NVS) $789,000 $1,148,000 $883,818 112%
Injection safety support (INS) $1,151,893 $1,151,893 $1,151,893 100%
IPV (NVS) $4,286,749 $4,286,749 $3,847,340 90%
JEV (NVS) $1,921,000 $1,921,000 $2,149,466 112%
JEV - Operational costs (OPC) $2,374,000 $2,374,000 $2,374,000 100%
Measles (NVS) $1,037,702 $1,037,702 $808,048 78%
MR-Follow-up campaign (NVS) $2,112,000 $2,112,000 $2,184,130 103%
MR-Follow-up campaign op.costs (OPC) $1,938,433 $1,938,433
Penta (NVS) $38,948,514 $41,294,514 $38,853,106 100%
Pneumo (NVS) $35,790,350 $46,162,850 $37,811,398 106%
Product Switch Grant (PSG) $160,636 $160,636 $160,636 100%
Rotavirus (NVS) N/A
Tetra DTP-HepB (NVS) $8,690,385 $8,690,385 $8,690,385 100%
Vaccine Introduction Grant (VIG) $3,152,078 $3,152,078 $3,152,078 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nepal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 90%
M:F sex ratio at birth (2018) 1.07
Household survey: DTP3 coverage for male (2013) 89.80%
Household survey: DTP3 coverage for female (2013) 86.50%
Household survey: Last DTP3 survey (2013) 88%
% districts achieving > 80% DTP3 coverage (2017) 70%
% districts achieving < 50% DTP3 coverage (2017) 1%
MCV WHO/UNICEF estimates (2017) 90%

Breakdown of support

Non-vaccine support Vaccine support
35% 65%
$53,269,505 $97,415,928

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nepal

09 May 2019

IPV

Inactivated polio vaccine now introduced worldwide

Momentous global effort enables record-breaking milestone for polio and immunisation.

03 April 2018

Typhoid vaccination in Nepal

New typhoid vaccine to receive Gavi support

Gavi has earmarked US$ 85 million to fund the introduction of the vaccine in the world’s poorest countries.

07 March 2018

Female vaccine heroes: two health workers, two scientists, a teacher and a town crier

If you know something about global health, you’ve probably heard of Edward Jenner or Jonas Salk, but what about the women who also helped lay the foundations for modern immunisation? Meet five remarkable women who pushed forward the frontiers of science.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here